227 related articles for article (PubMed ID: 25634012)
1. A Pharmacist's Impact on 30-Day Readmission Rates When Compared to the Current Standard of Care Within a Patient-Centered Medical Home: A Pilot Study.
Tedesco GW; McConaha JL; Skomo ML; Higginbotham SK
J Pharm Pract; 2016 Aug; 29(4):368-73. PubMed ID: 25634012
[TBL] [Abstract][Full Text] [Related]
2. Impact of pharmacist intervention in conjunction with outpatient physician follow-up visits after hospital discharge on readmission rate.
Arnold ME; Buys L; Fullas F
Am J Health Syst Pharm; 2015 Jun; 72(11 Suppl 1):S36-42. PubMed ID: 25991594
[TBL] [Abstract][Full Text] [Related]
3. Postdischarge pharmacist medication reconciliation: impact on readmission rates and financial savings.
Kilcup M; Schultz D; Carlson J; Wilson B
J Am Pharm Assoc (2003); 2013; 53(1):78-84. PubMed ID: 23636160
[TBL] [Abstract][Full Text] [Related]
4. Pharmacist-led transitions-of-care program reduces 30-day readmission rates for Medicare patients in a large health system.
Miller D; Ramsey M; L'Hommedieu TR; Verbosky L
Am J Health Syst Pharm; 2020 Jun; 77(12):972-978. PubMed ID: 32313954
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a multidisciplinary approach to reduce internal medicine readmissions using a readmission prediction index.
McConachie SM; Raub JN; Yost R; Monday L; Agrawal S; Tannous P
Am J Health Syst Pharm; 2020 Jun; 77(12):950-957. PubMed ID: 32382749
[TBL] [Abstract][Full Text] [Related]
6. The effect of a pharmacist-led multidisciplinary transitions-of-care pilot for patients at high risk of readmission.
Jones CD; Anthony A; Klein MD; Shakowski C; Smith HK; Go A; Perica K; Patel H; Pell J; Pierce R
J Am Pharm Assoc (2003); 2018; 58(5):554-560. PubMed ID: 30017370
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacist home visits and 30-day readmissions in Medicare Advantage beneficiaries.
Shcherbakova N; Tereso G
J Eval Clin Pract; 2016 Jun; 22(3):363-8. PubMed ID: 26695700
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a transitional care pharmacist intervention in a high-risk cardiovascular patient population.
Dempsey J; Gillis C; Sibicky S; Matta L; MacRae C; Kirshenbaum J; Faxon D; Churchill W
Am J Health Syst Pharm; 2018 Sep; 75(17 Supplement 3):S63-S71. PubMed ID: 29976830
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Early Versus Late Postdischarge Medication Reconciliation on Readmission Rates and Emergency Department Visits.
Joseph T; Barros RA; Kim E; Shah B
J Pharm Pract; 2018 Jun; 31(3):279-283. PubMed ID: 28539101
[TBL] [Abstract][Full Text] [Related]
10. Postdischarge community pharmacist-provided home services for patients after hospitalization for heart failure.
Kalista T; Lemay V; Cohen L
J Am Pharm Assoc (2003); 2015; 55(4):438-42. PubMed ID: 26161487
[TBL] [Abstract][Full Text] [Related]
11. Impact of a pharmacy team-led intervention program on the readmission rate of elderly patients with heart failure.
Moye PM; Chu PS; Pounds T; Thurston MM
Am J Health Syst Pharm; 2018 Feb; 75(4):183-190. PubMed ID: 29436465
[TBL] [Abstract][Full Text] [Related]
12. Heart Failure Transitions of Care: A Pharmacist-Led Post-Discharge Pilot Experience.
Milfred-LaForest SK; Gee JA; Pugacz AM; Piña IL; Hoover DM; Wenzell RC; Felton A; Guttenberg E; Ortiz J
Prog Cardiovasc Dis; 2017; 60(2):249-258. PubMed ID: 28826670
[TBL] [Abstract][Full Text] [Related]
13. Facilitating Home Hospice Transitions of Care in Oncology: Evaluation of Clinical Pharmacists' Interventions, Hospice Program Satisfaction, and Patient Representation Rates.
Duffy AP; Bemben NM; Li J; Trovato J
Am J Hosp Palliat Care; 2018 Sep; 35(9):1181-1187. PubMed ID: 29621893
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the effects of a multidisciplinary transition care management program on hospital readmissions.
Snyder ME; Krekeler CE; Jaynes HA; Davis HB; Lantaff WM; Shan M; Perkins SM; Zillich AJ
Am J Health Syst Pharm; 2020 Jun; 77(12):931-937. PubMed ID: 32436574
[TBL] [Abstract][Full Text] [Related]
15. Effects of a pharmacist-driven intervention program on hospital readmissions.
Shull MT; Braitman LE; Stites SD; DeLuca A; Hauser D
Am J Health Syst Pharm; 2018 May; 75(9):e221-e230. PubMed ID: 29691265
[TBL] [Abstract][Full Text] [Related]
16. Impact of pharmacist involvement in the transitional care of high-risk patients through medication reconciliation, medication education, and postdischarge call-backs (IPITCH Study).
Phatak A; Prusi R; Ward B; Hansen LO; Williams MV; Vetter E; Chapman N; Postelnick M
J Hosp Med; 2016 Jan; 11(1):39-44. PubMed ID: 26434752
[TBL] [Abstract][Full Text] [Related]
17. Impact of ambulatory care pharmacist intervention on 30-day readmission rates in high-risk transitions-of-care patients.
Sutt AR; Alm R; Olson JL
J Am Pharm Assoc (2003); 2023; 63(6):1694-1699. PubMed ID: 37169256
[TBL] [Abstract][Full Text] [Related]
18. Impact of a transition-of-care pharmacist during hospital discharge.
Balling L; Erstad BL; Weibel K
J Am Pharm Assoc (2003); 2015; 55(4):443-8. PubMed ID: 26161488
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Pharmacist Medication Education and Post-discharge Follow-up in Reducing Readmissions in Patients With ST-Segment Elevation Myocardial Infarction (STEMI).
Budiman T; Snodgrass K; Komatsu Chang A
Ann Pharmacother; 2016 Feb; 50(2):118-24. PubMed ID: 26681443
[TBL] [Abstract][Full Text] [Related]
20. Pharmacist-led program to improve transitions from acute care to skilled nursing facility care.
Achilleos M; McEwen J; Hoesly M; DeAngelo M; Jennings T
Am J Health Syst Pharm; 2020 Jun; 77(12):979-984. PubMed ID: 32377682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
